4//SEC Filing
Williams Kristen Marie 4
Accession 0001209191-22-035233
CIK 0001396814other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 7:46 PM ET
Size
11.5 KB
Accession
0001209191-22-035233
Insider Transaction Report
Form 4
Williams Kristen Marie
CAO and General Counsel
Transactions
- Award
Common Stock
2022-06-08+9,900→ 23,550 total - Sale
Common Stock
2022-06-06$61.37/sh−3,969$243,593→ 18,299 total - Sale
Common Stock
2022-06-07$59.51/sh−4,649$276,662→ 13,650 total - Award
Stock Option (Right to Buy)
2022-06-08+24,800→ 24,800 totalExercise: $59.39Exp: 2032-06-08→ Common Stock (24,800 underlying)
Footnotes (4)
- [F1]Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F3]Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- [F4]The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.
Documents
Issuer
Pacira BioSciences, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001296965
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 7:46 PM ET
- Size
- 11.5 KB